文献速递介入儿科影像腹部USCTMR

经颈静脉肝内门体分流术后长期可能伴发肝脏增生性结节病变:18例儿童及青年患者分析

Transjugular intrahepatic portosystemic shunt creation may be associated with hyperplastic hepatic nodular lesions in the long term: an analysis of 18 pediatric and young adult patients.
PubMed 文献 · Pediatr Radiol · 2021-03-30

回顾性分析18例TIPS通畅>3年的儿童及青年患者,TIPS创建时平均年龄12.5±5.1岁,平均MELD 8.1±1.6。9例(50%)在TIPS后平均4.4±3.0年影像随访中检出单个或多个肝脏结节,6例(33.3%)结节>1 cm且影像特征最符合局灶性结节性增生或FNH样结节。结论提示长期门体分流与肝脏结节性病变发生相关,建议将肝实质灰阶评估纳入常规超声并延长影像监测。

要点

  • TIPS通畅>3年的患儿中50%(9/18)出现肝脏结节,33.3%(6/18)结节>1 cm且影像最符合FNH或FNH样结节。
  • 结节出现于TIPS后平均4.4±3.0年(范围1.5–10.2年),影像监测需长期延续。
  • 建议将肝实质灰阶超声评估纳入TIPS患儿常规超声检查并延长影像监测。

关键影像表现/征象

  • 9例(50%)在TIPS后平均4.4±3.0年(范围1.5–10.2年)影像监测中检出单个或多个肝脏结节。
  • 6例(33.3%)出现>1 cm结节,影像特征最符合局灶性结节性增生或局灶性结节性增生样结节。

诊断标准与关键数值

  • TIPS技术成功率100%(18/18),其中1例(5.6%)创建为直接肝内门体分流。
  • 门体分流压力梯度平均下降9.1±3.3 mmHg(范围4–16 mmHg)。
  • 17例(94.4%)获得临床成功,初始TIPS指征缓解。
  • TIPS 3年原发通畅率83.3%(15/18)、原发辅助通畅率94.4%(17/18)、二次通畅率100%(18/18)。
  • 2例(11.1%)发生药物可控的轻度肝性脑病,1例(5.6%)发生肝肺综合征。

临床应用与阅片要点

  • 对TIPS术后长期随访的患儿,超声检查时应包含肝实质灰阶评估以检出结节性病变。
  • TIPS后平均4.4年可检出结节,影像监测宜延长至>3年直至更明确自然史。
  • 检出>1 cm结节时,影像特征可最符合FNH或FNH样结节,需结合增强影像进一步评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Retrospective studies have demonstrated the efficacy and safety of pediatric and adolescent transjugular intrahepatic portosystemic shunt (TIPS), but long-term outcomes warrant further investigation.

OBJECTIVE: To report on the development of hyperplastic hepatic nodular lesion development in children and young adults (<21 years) with TIPS patency >3 years.

MATERIALS AND METHODS: Eighteen children and young adults, including 10 (55.6%) females and 8 (44.4%) males, underwent TIPS creation with >3 years' patency and follow-up evaluation at a tertiary children's hospital. The mean age at the time of TIPS creation was 12.5±5.1 years (range: 1.5-20.0 years). The mean model for end-stage liver disease (MELD) at the time of TIPS creation was 8.1±1.6 (range: 6-11). Indications for TIPS creation included acute variceal bleeding (8/18, 44.4%), primary (1/18, 5.6%) or secondary (7/18, 38.9%) prevention of varices, portal vein thrombosis (1/18, 5.6%), and splenic sequestration (1/18, 5.6%). Technical successes, intra-procedural parameters, hemodynamic and clinical successes, TIPS patencies, adverse events, imaging evaluations, and follow-ups were recorded.

RESULTS: All (100%) TIPS placements were successful; however, a direct intrahepatic portosystemic shunt was created in one (5.6%) patient. Mean reduction of the portosystemic shunt gradient was 9.1±3.3 mmHg (range: 4-16 mmHg). Seventeen (94.4%) patients demonstrated clinical success with resolution of their initial clinical indication for TIPS placement. The 3-year TIPS primary, primary-assisted, and secondary patencies were 83.3% (15/18), 94.4% (17/18), and 100% (18/18), respectively. Two (11.1%) patients developed mild, medically controlled hepatic encephalopathy. One (5.6%) patient developed hepatopulmonary syndrome. Nine (50%) patients developed single or multiple hepatic nodules at a mean imaging surveillance time after TIPS of 4.4±3.0 years (range: 1.5-10.2 years). Six (33.3%) patients developed nodules >1 cm with imaging features most consistent with focal nodular hyperplasia or focal nodular hyperplasia-like nodules. The mean follow-up duration was 5.7±2.9 years (range: 3.0-13.1 years).

CONCLUSION: Long-term (>3 years) portosystemic shunting via TIPS is associated with the development of hepatic nodular lesions in children. Consequently, children with TIPS may need gray-scale assessment of hepatic parenchyma as part of routine ultrasound exams and extended imaging surveillance until more is understood regarding the natural history of induced nodularity.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Woerner AJ, Shin DS, Chick JFB, et al. Transjugular intrahepatic portosystemic shunt creation may be associated with hyperplastic hepatic nodular lesions in the long term: an analysis of 18 pediatric and young adult patients. Pediatr Radiol. 2021. PMID: 33783576. doi:10.1007/s00247-021-05010-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。